JNJ · outlook

Johnson & Johnson: what the data says

A diversified healthcare giant spanning pharmaceuticals, medical devices, and consumer products, traditionally viewed as a low-volatility defensive stock. In 2023 it spun off its consumer health division (Kenvue) to focus more tightly on higher-margin pharmaceuticals and medical devices.